Loading…
Aura Biosciences, Inc. is projected to rise to $7.52 by 2027, a +7% move from its current price of $7.01. AURA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $6.84 | $7.01 | $7.19 | +0.03% |
| Aug 3 | $6.77 | $7.01 | $7.26 | +0.06% |
| Aug 4 | $6.72 | $7.02 | $7.32 | +0.09% |
| Aug 5 | $6.68 | $7.02 | $7.37 | +0.12% |
| Aug 6 | $6.64 | $7.02 | $7.42 | +0.15% |
| Aug 7 | $6.61 | $7.02 | $7.46 | +0.18% |
| Aug 8 | $6.58 | $7.03 | $7.50 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.58 | $7.03 | $7.50 | +0.21% |
| Week 2 | $6.42 | $7.04 | $7.72 | +0.43% |
| Week 3 | $6.30 | $7.06 | $7.90 | +0.64% |
| Week 4 | $6.20 | $7.07 | $8.06 | +0.86% |
| Week 5 | $6.12 | $7.09 | $8.20 | +1.08% |
| Week 6 | $6.05 | $7.10 | $8.34 | +1.29% |
| Week 7 | $5.98 | $7.12 | $8.46 | +1.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aura Biosciences, Inc. is a clinical-stage biotechnology company that develops precision therapies to treat solid tumors. Its lead candidate bel-sar is in late-stage clinical development for the treatment of primary choroidal melanoma and other ocular oncology indications, and it is in early-stage clinical development in bladder cancer.
The company focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. Aura Biosciences was incorporated in 2009. It is headquartered in Boston, Massachusetts.
Aura Biosciences, Inc. (AURA) trades at $7.09 per share. Its market capitalization is $733.36M, and it ranks 2744. The current price action sits within a context of a neutral-to-bullish long-range forecast. For 2026, the average price is forecast to be $7.09 with a min of $4.97 and a max of $8.94, yielding a neutral sentiment.
A major floor 19.7% below — a decisive break under it would weaken the trend.
The nearest floor, 9.6% below — buyers have tended to step in here.
The nearest ceiling, 10.4% above — a clean break opens room to run.
A major ceiling 27.0% above — clearing it would confirm fresh momentum.
Key AURA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AURA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.07 | Sell | $7.05 | Sell |
| MA 10 | $7.05 | Sell | $7.05 | Sell |
| MA 20 | $7.03 | Sell | $7.02 | Sell |
| MA 50 | $6.96 | Buy | $7.00 | Buy |
| MA 100 | $7.00 | Buy | $6.86 | Buy |
| MA 200 | $6.37 | Buy | $6.69 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.89 | Neutral |
| Stoch RSI (14) | 37.50 | Neutral |
| CCI (20) | -16.15 | Neutral |
| Williams %R (14) | -50.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.46 | Neutral |
| Stochastic %K (14) | 50.00 | Neutral |
| TRIX (15) | 0.06 | Buy |
| Awesome (5,34) | 0.14 | Buy |
| Ultimate (7,14,28) | 50.18 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 7.04 | Sell |
| ADX (14) | 6.17 | Neutral |
| ATR (14) | 0.15 | Info |
The 30-day technical picture shows bullish sentiment, with RSI(14) at 50. The stock trades above the SMA200 of $6.28 and near the SMA50 of $7.22, indicating a constructive near-term trend.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.97 | $7.01 | $8.71 | 0% | Neutral | |
| $6.05 | $7.52 | $9.85 | +7% | Neutral | |
| $7.26 | $9.26 | $12.56 | +32% | Bullish | |
| $8.44 | $10.99 | $15.31 | +57% | Bullish | |
| $8.48 | $11.25 | $16.04 | +61% | Bullish | |
| $8.90 | $12.00 | $17.45 | +71% | Bullish | |
| $9.12 | $12.49 | $18.47 | +78% | Bullish | |
| $9.28 | $12.89 | $19.39 | +84% | Bullish | |
| $10.83 | $15.25 | $23.27 | +118% | Bullish | |
| $11.93 | $17.03 | $26.34 | +143% | Bullish | |
| $15.17 | $22.97 | $37.65 | +228% | Bullish | |
| $27.25 | $45.63 | $81.39 | +551% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.97 | $7.01 | $8.42 | +0.00% |
| September 2026 | $5.94 | $7.01 | $8.49 | +0.02% |
| October 2026 | $6.07 | $7.21 | $8.82 | +2.81% |
| November 2026 | $6.08 | $7.25 | $8.94 | +0.63% |
| December 2026 | $5.85 | $7.01 | $8.71 | -3.34% |
Click any year to see its month-by-month AURA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, AURA could reach as high as $8.71, with a base case around $7.01 and support toward $4.97 — roughly 0% from $7.01. Price action looks broadly range-bound.
Expect AURA to range from $6.05 to $9.85 through 2027. The $7.52 average target implies a +7% move from current prices. That is up +7% on the projected 2026 average. A consolidation phase looks the most probable path here.
The AURA price prediction for 2028 points to an average of $9.26 (low $7.26, high $12.56) — a potential gain of +32% on today's $7.01. Momentum favours further upside here.
In 2029, AURA is projected to trade between $8.44 and $15.31, averaging $10.99 — a potential gain of +57% from today's $7.01. That is up +19% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Aura Biosciences, Inc.'s 2030 outlook centres on $11.25, within a $8.48 to $16.04 range. That is up +2% on the projected 2029 average. That marks a +61% change versus current levels. Momentum favours further upside here.
By 2031, AURA could reach as high as $17.45, with a base case around $12.00 and support toward $8.90 — roughly +71% from $7.01. Buyers look set to stay in control over this stretch.
Expect AURA to range from $9.12 to $18.47 through 2032. The $12.49 average target implies a +78% move from current prices. That is up +4% on the projected 2031 average. Momentum favours further upside here.
The AURA price prediction for 2033 points to an average of $12.89 (low $9.28, high $19.39) — a potential gain of +84% on today's $7.01. Buyers look set to stay in control over this stretch.
In 2034, AURA is projected to trade between $10.83 and $23.27, averaging $15.25 — a potential gain of +118% from today's $7.01. That is up +18% on the projected 2033 average. Momentum favours further upside here.
Aura Biosciences, Inc.'s 2035 outlook centres on $17.03, within a $11.93 to $26.34 range. That is up +12% on the projected 2034 average. That marks a +143% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, AURA could reach as high as $37.65, with a base case around $22.97 and support toward $15.17 — roughly +228% from $7.01. Momentum favours further upside here.
Expect AURA to range from $27.25 to $81.39 through 2050. The $45.63 average target implies a +551% move from current prices. That is up +99% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in AURA today (≈ 142.653352 AURA) could be worth
$6,509.79
+$5,509.79 (+551%) by 2050 · US Dollar
Based on the average projected AURA price of $45.63 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AURAwould be worth at today's price.
$1,000 invested in AURA on Jul 31, 2025 (≈ 145.137884 AURA) would be worth
$1,017.42
+$17.42 (+1.7%) today · 1.02× · US Dollar
Based on a AURA entry price of $6.89 vs. today's $7.01.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.05 | $994.33 | -0.6% |
| 1 month ago | $6.73 | $1,041.6 | +4.2% |
| 3 months ago | $7.01 | $1,000 | -0.0% |
| 6 months ago | $5.88 | $1,192.18 | +19.2% |
| 1 year ago | $6.89 | $1,017.42 | +1.7% |
| All time (4.8y) ago | $14.8 | $473.65 | -52.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AURA forecast.
Our base-case forecast reaches $14.00 around 2034.
Implied market cap at $14.00: $1.45B
The multi-year forecast points to a bullish trajectory with rising average prices and meaningful upside. In 2030, the average price is $13.69, with a min of $9.43 and a max of $21.56, and a ROI of 93.1% as the sentiment remains BULLISH. By 2040, the average price is $31.27, the max is $59.56 and the min is $17.02, delivering a ROI of 341.1% with a BULLISH sentiment.
In 2050, the average price is $64.20, the max $136.61 and the min $28.89, for a ROI of 805.4% with a BULLISH sentiment. The forecast also shows progressive years such as 2027 (avg $8.35; min $6.39; max $11.68) and 2028 (avg $10.66; min $7.83; max $15.65), reflecting an upward trajectory. These are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $13.69, a min of $9.43, a max of $21.56, with a ROI of 93.1% and bullish sentiment.
Forecasts show rising averages over time with positive ROIs in multiple years (e.g., 2030 ROI 93.1%, 2040 ROI 341.1%, 2050 ROI 805.4%), but 2026 is neutral and forecasts are estimates, not guarantees.
The 2040 max is $59.56, which is just below $60, with an average of $31.27 and a ROI of 341.1%.
2027 average price is $8.35 (min $6.39, max $11.68). 2028 average price is $10.66 (min $7.83, max $15.65). Both carry bullish sentiment.
Forecasts are estimates and not guarantees; actual results may vary across years and ROIs.
Aura Biosciences, Inc. Community Discussion
0Share your Aura Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.